Introduction {#s1}
============

A complex interplay between endodermal and mesodermal cell types defines early developmental competence and cell fate in the lung. As such, proximal-distal patterning of the lung is accompanied by the gradual restricted ability of developmental progenitors to generate the various epithelial lineages in the mature organ [@pone.0071426-Rawlins1]. During lung development, *Fgf10 (Fibroblast growth factor 10)* is expressed in mesenchyme distal to the branching tips where it maintains the multipotent distal epithelial progenitors, but is suppressed proximally and at bifurcation points [@pone.0071426-Bellusci1], [@pone.0071426-DeLanghe1], [@pone.0071426-DeLanghe2], [@pone.0071426-Goss1], [@pone.0071426-Nyeng1], [@pone.0071426-Ramasamy1]. We previously identified the *Fgf10*-expressing cells in the distal mesenchyme as parabronchial smooth muscle cell (PSMC) progenitors [@pone.0071426-DeLanghe1], [@pone.0071426-Mailleux1]. *Fgf10* expression as well as the amplification of these PSMC progenitors is regulated by Wnt signaling [@pone.0071426-DeLanghe1], [@pone.0071426-Chen1], [@pone.0071426-Goss2]. Suppression of *Fgf10* expression around the developing airway is crucial to allow for proper maturation of the lung airway epithelium [@pone.0071426-Sedita1], [@pone.0071426-Izvolsky1], [@pone.0071426-McKeehan1], [@pone.0071426-Izvolsky2], [@pone.0071426-Shimokawa1].

The adult lung is a vital and complex organ that normally turns over very slowly. The epithelial cells that line the airways are constantly exposed to potential toxic agents and pathogens in the environment, and they must therefore be able to respond quickly and effectively to both cellular damage and local production of immune cytokines. Adult stem cells are implicated in both homeostatic tissue maintenance and functional restoration after injury in organs such as skin and gut.

A widely used lung injury model involves the destruction of Clara cells by naphthalene. Only those Clara cells that express cytochrome P4502F2 (encoded by *Cyp2f2*) are able to convert naphthalene into toxic epoxides leading to cell death. Within a few hours after naphthalene administration nearly all Clara cells have died, except for the few less differentiated variant Clara stem cells that do not express *Cyp2f2*, making them therefore resistant against naphthalene [@pone.0071426-Giangreco1], [@pone.0071426-Hong1], [@pone.0071426-Plopper1], [@pone.0071426-Reynolds1], [@pone.0071426-Stripp1]. Ciliated cells quickly spread out, or squamate, under the dying Clara cells in an attempt to cover the basal lamina and maintain the permeability barrier of the epithelium [@pone.0071426-Park1].

We have previously shown that surviving ciliated cells after naphthalene, ozone or bleomycin-mediated airway epithelial injury start to secrete Wnt7b, which then activates the PSMC niche to induce *Fgf10* expression [@pone.0071426-Volckaert1]. We found that Fgf10 secreted by the niche acts on surviving Clara stem cells to break quiescence, induce proliferation and initiate epithelial repair. Here we show that after naphthalene-mediated airway epithelial injury, the Wnt target c-Myc is important for the activation of the PSMC niche and as such induces proliferation and *Fgf10* expression in PSMCs. Myc proteins coordinate many interdependent processes, including cell growth (increase in cell mass), cell proliferation (DNA replication and cell cycle progression), differentiation and apoptosis [@pone.0071426-Dang1]. Using an allelic series of mice in which *c-Myc* expression was incrementally reduced to zero, Trumpp et al. showed that fibroblasts from these mice exhibit reduced proliferation and after complete loss of c-Myc function exit the cell cycle [@pone.0071426-Trumpp1]. Our data indicate that conditional deletion of *c-Myc* from PSMCs prevents activation of the airway epithelial stem cell niche after airway epithelial injury resulting in deficient epithelial repair.

Results {#s2}
=======

c-Myc Expression in the Lung Mesenchyme is not Required for Normal Lung Development {#s2a}
-----------------------------------------------------------------------------------

During lung development, *Nmyc* expression is normally restricted to a distal population of undifferentiated epithelial cells [@pone.0071426-Okubo1], whereas *c-Myc* is only expressed in the mesenchyme [@pone.0071426-DeLanghe1]. *c-Myc* expression is regulated by β-catenin signaling and is lost upon conditional deletion of *β-catenin* from the lung mesenchyme [@pone.0071426-DeLanghe1]. In some organs most of the effects of β-catenin signaling are primarily mediated by *c-Myc* [@pone.0071426-Sansom1]. To test whether during lung development the effects of mesenchymal β-catenin signaling are primarily mediated via *c-Myc* we conditionally deleted *c-Myc* from the lung mesenchyme using a *Dermo1(Twist2)-Cre* line [@pone.0071426-Yu1]. Interestingly, while ablation of *β-catenin* from the lung mesenchyme resulted in major differentiation defects and reduced *Fgf10* expression [@pone.0071426-DeLanghe1], [@pone.0071426-Yin1], we found that conditional deletion of *c-Myc* from the lung mesenchyme has no significant effect on either ([Fig. 1A--D](#pone-0071426-g001){ref-type="fig"}). At E18.5, *Dermo1-Cre;c-Myc^f/f^* [@pone.0071426-Trumpp1] conditional knock out lungs appear normal, with normal *Fgf10* expression ([Fig. 1A,B](#pone-0071426-g001){ref-type="fig"}) and with proper differentiation of the airway and vascular smooth muscle cells ([Fig. 1C,D](#pone-0071426-g001){ref-type="fig"}), proper differentiation of the distal epithelium in ATII (Sftpc) and ATI (Pdpn) cells ([Fig. 1C--F](#pone-0071426-g001){ref-type="fig"}) and proper differentiation of the bronchial epithelium into Clara (Scgb1a1) and ciliated cells (ß-Tub) ([Fig. 1G,H](#pone-0071426-g001){ref-type="fig"}).

![Mesenchyme-specific *c-Myc* ablation does not affect lung development.\
(A,B) *Fgf10* in situ hybridization on E18.5 ctrl (A) and *Dermo1-Cre;c-Myc^f/f^* (B) lungs showing that *Fgf10* expression is not affected. (C--H) Immunostaining for α-SMA (smooth muscle cells) and Sftpc (ATII cells) (C,D), PDPN (ATI cells) (E,F), and Scgb1a1 (Clara cells) and β-tubulin (ciliated cells) (G,H) on E18.5 ctrl (C,E,G) and *Dermo1-Cre;c-Myc^f/f^* (D,F,H) lungs. n≥3. Scale bars: 100 µM (A,B and G,H); 200 µM (C--F).](pone.0071426.g001){#pone-0071426-g001}

c-Myc Regulates Activation of the Airway Epithelial Stem Cell Niche after Airway Epithelial Injury {#s2b}
--------------------------------------------------------------------------------------------------

We recently showed that after airway epithelial injury, surviving epithelial cells secrete Wnt7b, which then activates PSMCs (which constitute a niche for airway epithelial stem cells) to induce proliferation and *Fgf10* expression [@pone.0071426-Volckaert1]. This Fgf10 secreted by the PSMC niche then acts on a subset of Clara stem cells to break quiescence, induce proliferation and initiate epithelial repair [@pone.0071426-Volckaert1]. To investigate the requirement of *c-Myc* in the activation of the PSMC niche and the induction of *Fgf10* expression in the adult lung after airway epithelial injury we generated *Myh11-Cre;c-Myc^f/f^* mice (Myh11: smooth muscle myosin heavy chain) [@pone.0071426-Xin1], in which we conditionally deleted *c-Myc* from the PSMCs, shown by in situ hybridization in [Fig. 2A,B](#pone-0071426-g002){ref-type="fig"}. Interestingly, we found that the PSMC niche in *Myh11-Cre;c-Myc^f/f^* lungs does not get activated after naphthalene-mediated airway epithelial injury. This is manifested by reduced proliferation of the PSMCs, as 9.2% ±1% of PSMCs were BrdU positive in control lungs vs. 2.6% ±0.23% of PSMCs in *Myh11-Cre;c-Myc^f/f^* lungs (*P = *0.000005, n≥4) ([Fig. 2C,D](#pone-0071426-g002){ref-type="fig"}) [@pone.0071426-Volckaert1]. To investigate whether induction of *Fgf10* expression is also regulated by c-Myc we crossed *Myh11-Cre;c-Myc^f/f^* mice with an *Fgf10^LacZ^* reporter line [@pone.0071426-DeLanghe1], [@pone.0071426-Ramasamy1], [@pone.0071426-Mailleux1], [@pone.0071426-Volckaert1], [@pone.0071426-Kelly1]. In contrast to our observations during lung development we found that in the adult lung, 3 days after naphthalene-mediated airway epithelial injury, *Fgf10* expression in the PSMC niche is regulated by c-Myc, as demonstrated by the lack of induction of *Fgf10* expression in *Myh11-Cre;c-Myc^f/f^;Fgf10^LacZ^* mice ([Fig. 2F](#pone-0071426-g002){ref-type="fig"}) compared to control littermates ([Fig. 2E](#pone-0071426-g002){ref-type="fig"}). We previously reported a similar drastic reduction in *Fgf10* expression and proliferation in PSMCs, after naphthalene-mediated airway epithelial injury, in mice overexpressing *Dkk1*, a secreted inhibitor of Wnt signaling [@pone.0071426-Volckaert1]. To investigate whether epithelial Fgf10 signaling is also reduced we checked for Scgb1a1+Sftcp+ [@pone.0071426-Volckaert1], [@pone.0071426-Kim1] and Scgb1a1+Fgfr2b+ [@pone.0071426-Volckaert1] double positive Clara stem cells in the regenerating distal airways near bronchoalveolar duct junctions (BADJs). In accordance with our previously reported results showing that Sftpc and Fgfr2b expression in Clara stem cells is at least in part regulated by Fgf10 [@pone.0071426-Volckaert1], we found a reduction in Scgb1a1+Sftcp+ and Scgb1a1+Fgfr2b+ double positive distal airway Clara stem cells at the BADJs in *Myh11-Cre;c-Myc^f/f^* mice 7 days after naphthalene injury compared to control littermates ([Fig. 3A--D](#pone-0071426-g003){ref-type="fig"}) [@pone.0071426-Volckaert1], [@pone.0071426-Kim1], [@pone.0071426-Chen2].

![*c-Myc* regulates activation of the airway epithelial stem cell niche after airway epithelial injury.\
(A,B) *c-Myc* in situ hybridization on ctrl (A) and *Myh11-cre;c-Myc^f/f^* (B) lungs 7 days after naphthalene injury, showing that *c-Myc* is expressed by airway smooth muscle cells after airway epithelial injury and the absence of *c-Myc* expression in *Myh11-cre;c-Myc^f/f^* lungs. (C,D) Immunostaining for BrdU (proliferation marker) and α-SMA (airway smooth muscle cells) on ctrl (C) and *Myh11-cre;c-Myc^f/f^* (D) lungs 3 days after naphthalene treatment. (E,F) β-gal staining on *Fgf10^LacZ^* ctrl (E) and *Myh11-cre;c-Myc^f/f^;Fgf10^LacZ^* (F) lungs 3 days after naphthalene injury. n≥3. Scale bars: 50 µM (A,B); 100 µM (C,D); 200 µM (E,F).](pone.0071426.g002){#pone-0071426-g002}

![Conditional *c-Myc* deletion from PSMCs reduces Fgf10 signaling in Clara stem cells after naphthalene-mediated injury.\
(A--D) Immunostaining for Scgb1a1 and Sftpc (A,B), Scgb1a1 and Fgfr2b (C,D) on ctrl (A,C) and *Myh11-cre;c-Myc^f/f^* (B,D) lungs 7 days after naphthalene. n≥3. Scale bars: 50 µM (A--D).](pone.0071426.g003){#pone-0071426-g003}

Conditional Deletion of c-Myc from Airway Smooth Muscle Severely Impairs Airway Epithelial Regeneration After Injury {#s2c}
--------------------------------------------------------------------------------------------------------------------

Fgf10 secreted by the PSMC niche after airway epithelial injury is critical for proper regeneration of the airway epithelium [@pone.0071426-Volckaert1]. We next investigated how airway epithelial regeneration is affected in *Myh11-Cre;c-Myc^f/f^* mice with a conditional inactivation of *c-Myc* from the PSMC niche. *Myh11-Cre;c-Myc^f/f^* and control littermates were injured with naphthalene resulting in a \>95% decrease in *Scgb1a1* expression, as a measure of Clara cell loss, by 3 days after injury and airway epithelial regeneration was monitored over time. At 3 days post injury both control and *Myh11-Cre;c-Myc^f/f^* mice show similar levels of injury demonstrated by low levels of *Scgb1a1* mRNA expression (a Clara stem cell-specific marker) and the presence of limited Scgb1a1 positive Clara stem cells at BADJs and near CGRP-expressing neuroendocrine bodies, while most of the airway is lined with ciliated cells (β-tubulin) ([Fig. 4A,D,G,J,M](#pone-0071426-g004){ref-type="fig"}). At 7 days after injury, *Myh11-Cre;c-Myc^f/f^* mice show a 40% decrease in airway epithelial regeneration ([Fig. 4H,K,M](#pone-0071426-g004){ref-type="fig"}) compared to control mice ([Fig. 4B,E,M](#pone-0071426-g004){ref-type="fig"}). This decrease in regeneration is even more evident at 14 days post injury, with *Myh11-Cre;c-Myc^f/f^* mice showing an almost 3 fold decrease in regeneration ([Fig. 4I,L,M](#pone-0071426-g004){ref-type="fig"}) compared to control mice ([Fig. 4C,F,M](#pone-0071426-g004){ref-type="fig"}).

![Conditional *c-Myc* deletion from the epithelial stem cell niche impairs epithelial regeneration after injury.\
(A--L) Immunostaining for Scgb1a1 (Clara stem cells) and β-tubulin (ciliated cells) (A--C,G--I) or Scgb1a1 (Clara stem cells) and CGRP (neuroendocrine bodies) (D--F,J--L) on ctrl (A--F) and *Myh11-cre;c-Myc^f/f^* (G--L) lungs 3 days (A,D,G,J), 7 days (B,E,H,K) and 14 days (C,F,I,L) after naphthalene injury. (M) qPCR analysis of relative *Scgb1a1* mRNA abundance in lungs from ctrl and *Myh11-cre;c-Myc^f/f^* mice 3, 7 and 14 days after naphthalene treatment. \*\**P*\<0.01, \**P*\<0.05 vs. respective control. n≥3. Scale bars: 200 µM (A--C and G--I); 50 µM (D--F and J--L).](pone.0071426.g004){#pone-0071426-g004}

Conditional Deletion of c-Myc from Clara Stem Cells does not Affect Airway Epithelial Regeneration after Injury {#s2d}
---------------------------------------------------------------------------------------------------------------

We have previously shown that after naphthalene injury a subset of Clara cells undergo a transient epithelial to mesenchymal transition (EMT) to acquire stem cell-like properties and as such are able to transiently induce the expression of *Myh11* [@pone.0071426-Volckaert1]. To investigate whether the decrease in airway epithelial regeneration in *Myh11-Cre;c-Myc^f/f^* mice is not due to deletion of *c-Myc* from these Clara cells, transiently expressing *Myh11-Cre*, we generated *Scgb1a1-Cre;c-Myc^f/f^* [@pone.0071426-Ji1], [@pone.0071426-Simon1] mice in which the *c-Myc* gene is deleted specifically from all Clara cells. We found that airway epithelial regeneration after naphthalene injury is not affected in *Scgb1a1-Cre;c-Myc^f/f^* mice compared to control littermates ([Fig. 5A--E](#pone-0071426-g005){ref-type="fig"}), indicating that epithelial c-Myc does not play an important role in airway epithelial regeneration and that the defect in regeneration observed in *Myh11-Cre;c-Myc^f/f^* mice can be attributed solely to the loss of *c-Myc* from the PSMC niche. This is consistent with the fact that during lung development *c-Myc* expression is restricted to the mesenchyme, whereas *Nmyc* is expressed solely in the epithelium [@pone.0071426-DeLanghe1], [@pone.0071426-Okubo1].

![Epithelial *c-Myc* deletion does not affect airway epithelial regeneration after injury.\
(A--D) Immunostaining for Scgb1a1 (Clara stem cells) and β-tubulin (ciliated cells) (A,B) or Scgb1a1 (Clara stem cells) and CGRP (neuroendocrine bodies) (C,D) on ctrl (A,C) and *Scgb1a1-Cre;c-Myc^f/f^* (B,D) lungs 7 days after naphthalene injury. (E) qPCR analysis of relative *Scgb1a1* mRNA abundance in lungs from ctrl and *Scgb1a1-Cre;c-Myc^f/f^* mice 7 days after naphthalene treatment. *P*\>0.05, n≥3. Scale bars: 200 µM (A,B); 50 µM (C,D).](pone.0071426.g005){#pone-0071426-g005}

Discussion {#s3}
==========

The lung has a complex three-dimensional structure that features major differences along its proximal-distal axis in terms of the composition of the endoderm-derived epithelium. The trachea and primary lung buds arise by different morphogenetic processes from contiguous regions of the embryonic foregut [@pone.0071426-Cardoso1]. A distinguishing feature of the adult mouse cartilaginous airways (i.e. trachea and primary bronchi) is that *Fgf10* is expressed in the mesenchyme between the cartilage rings [@pone.0071426-Sala1], [@pone.0071426-Tiozzo1] and that they contain a discontinuous population of basal stem cells that express p63 and specific keratins (K14 and K5). In addition to basal cells, the luminal epithelium in cartilaginous airways consists of two main columnar epithelial cell types: ciliated cells and Clara cells with a limited number of Clara cell-derived goblet cells. Ciliated cells contain cilia which are involved in the clearance of mucus produced by goblet cells, whereas Clara cells produce secretoglobins, the most abundant of which is Scgb1a1 (also known as CCSP, CC10 and CCA) [@pone.0071426-Rawlins2], [@pone.0071426-Rock1], [@pone.0071426-Rock2].

The more distal airways (small bronchi and bronchioles) have a columnar epithelium surrounded by airway smooth muscle which does not express *Fgf10* during normal homeostasis [@pone.0071426-Mailleux1]. Clara stem cells predominate over ciliated cells and there are more neuroendocrine cells than in the trachea. More importantly, there is no evidence of basal cells in smaller airways in the mouse during normal homeostasis [@pone.0071426-Pack1].

In the cartilaginous airways basal cells are considered to be on top of the stem cell hierarchy and are able to self renew and give rise to both Clara cells, goblet cells and ciliated cells [@pone.0071426-Rock3]. Clara cells themselves are also considered stem cells and during normal homeostasis can give rise to new Clara cells and terminally differentiated ciliated cells [@pone.0071426-Evans1], [@pone.0071426-Rawlins3]. Cellular plasticity (including but not limited to differentiation, dedifferentiation, and transdifferentiation) is a frequently encountered cell behavior during injury repair [@pone.0071426-Barroca1], [@pone.0071426-Bedada1], [@pone.0071426-Cobaleda1], [@pone.0071426-Kai1], [@pone.0071426-Stocum1], [@pone.0071426-Stocum2], [@pone.0071426-Zhou1]. Interestingly, p63 is a master regulator required for the development of basal cells [@pone.0071426-Daniely1] and induces a basal cell phenotype and squamous metaplasia when ectopically expressed in Clara cells [@pone.0071426-Koster1]. This form of Clara cell reprogramming may happen to some extent after airway epithelial injury, as under such conditions Clara cells have been shown to be able to give rise to basal cells [@pone.0071426-Rawlins3].

Interestingly, our unpublished data suggest that Fgf10 plays a role in the differentiation of airway epithelial cells into basal stem cells during lung development (Volckaert et al., manuscript submitted).

Our data presented here indicate that c-Myc plays an important role in regulating the activity of the PSMC niche in the adult lung. We found a role for c-Myc in regulating proliferation of PSMCs as well as the induction of *Fgf10* expression within PSMCs cells after airway epithelial injury. Interestingly, we found no important role for c-Myc in the mesenchyme during lung development indicating that the function of c-Myc during lung development is redundant and that other not yet identified factors may compensate for the loss of *c-Myc* during lung development. The lack of defective smooth muscle cell differentiation or maintenance in *Myh-Cre;c-Myc^f/f^* lungs suggests that c-Myc may play a specific role in activation of the PSMC niche after injury. Together with the finding that epithelial c-Myc does not play an important role in lung epithelial homeostasis or repair after injury we conclude that targeting c-Myc may be a great way to treat lung diseases characterized by abnormal proliferation of smooth muscle cells, such as asthma and pulmonary arterial hypertension in which Wnt signaling plays a role [@pone.0071426-Cohen1]. In addition, we have previously shown that *Fgf10* secreted by the PSMCs modulates the differentiation of Clara cells into goblet cells [@pone.0071426-Volckaert1], which is a hallmark of the asthmatic airway. Future experiments will be needed to determine if loss of mesenchymal *c-Myc* may also reduce proliferation of (myo)fibroblasts in the bleomycin model of pulmonary fibrosis, in which Wnt signaling plays an important role [@pone.0071426-Konigshoff1], [@pone.0071426-Konigshoff2], [@pone.0071426-Konigshoff3], [@pone.0071426-Xi1], [@pone.0071426-Ulsamer1], [@pone.0071426-Kim2], [@pone.0071426-Kim3]. If so, targeting c-Myc might be an effective and selective way to treat fibroproliferative lung diseases in general.

Materials and Methods {#s4}
=====================

Study Approval {#s4a}
--------------

All experiments were conducted in strict accordance with the recommendations in the guide for the care and use of laboratory animals. The protocol was approved by the National Jewish Health institutional animal care and use committee \#AS2774.

Mouse Strains {#s4b}
-------------

*Myh11-Cre \[Tg(Myh11-cre,-EGFP)2Mik/J\]* mice were obtained from Jackson Laboratories. *Dermo1-Cre* mice were a kind gift from Dr. David Ornitz [@pone.0071426-Yu1]. *Scgb1a1-Cre* were a kind gift from Dr. Thomas Mariani [@pone.0071426-Ji1], [@pone.0071426-Simon1]. *c-Myc^f/f^* mice were a kind gift from Dr. Andreas Trumpp [@pone.0071426-Trumpp1]. Adult mice were 8 weeks old at time of naphthalene administration. Animals were maintained in a pathogen-free environment.

β-gal Staining {#s4c}
--------------

Tissues containing *Fgf10^LacZ^* allele were dissected, and β-gal staining was performed at 3 days after naphthalene injury. Lungs were dissected and fixed in 4% PFA in PBS at room temperature for 5 minutes, rinsed in PBS, injected with freshly prepared X-gal solution, transferred into a vial of X-gal solution, and stained at 37°C overnight. After rinsing with PBS, lungs were postfixed in 4% PFA in PBS at room temperature overnight. For microtome sections, after 4% PFA fixation, lungs were washed in PBS, dehydrated, and paraffin embedded.

Immunofluorescence {#s4d}
------------------

All staining was done on paraffin sections of formalin-fixed lungs. Immunofluorescent staining was performed with the following primary antibodies: mouse anti--β-tubulin (3F3-G2; Seven Hills Bioreagents), goat anti-Scgb1a1 (T-18; Santa Cruz Biotechnology Inc.), rabbit anti-Scgb1a1 (Seven Hills Bioreagents), rabbit anti-CGRP (Sigma-Aldrich), rabbit anti-Fgfr2 (Bek) (C-17; Santa Cruz Biotechnology Inc.), mouse anti--α-SMA cy3 conjugate and unconjugated (14A; Sigma-Aldrich), rabbit anti-Sftpc (Seven Hills Bioreagents), mouse anti-PDPN (Iowa hybridoma bank). All fluorescent staining was performed with secondary antibodies from Jackson Immunoresearch (except the Cy3-conjugated α-SMA) and mounted using Vectashield with DAPI (Vector Labs). Photographs were taken with a Zeiss AxioImager and Axiovision software.

qPCR {#s4e}
----

RNA was isolated from lung accessory lobes using RNALater (Ambion) and Total RNA Kit I (Omega Biotek) according to the manufacturer's instructions. RNA concentration was determined by spectrophotometry. cDNA was generated using SuperScript III First-Strand Synthesis System (Invitrogen) according to the manufacturer's instructions. Comparative real-time PCR was performed for *β-glucuronidase* (Mm00446953_m1) and *Scgb1a1* (Mm00442046_m1) Taqman Gene Expression Assays (Applied Biosystems) using a StepOne Plus system (Applied Biosystems). *β-glucuronidase* was used as a reference control to normalize equal loading of template cDNA.

Naphthalene Treatment {#s4f}
---------------------

Naphthalene (Sigma-Aldrich) was dissolved in corn oil at 30 mg/ml and administered intraperitoneally at 8 weeks of age, with doses adjusted according to strain to achieve a 95% decrease in the abundance of *Scgb1a1* mRNA in total lung RNA of WT mice at 3 days after injection. Control mice for regeneration studies were WT littermates.

Proliferation {#s4g}
-------------

Mice were given intraperitoneal injections of 10 µl BrdU (GE Healthcare) per gram body weight 4 hours before sacrifice. Lungs were fixed in 4% paraformaldehyde, dehydrated, and paraffin embedded. Sections were treated with monoclonal anti-BrdU (clone BU-1; GE Healthcare) according to the manufacturer's instructions. FITC-labeled anti-mouse secondary antibodies were used (Jackson Immunoresearch). All slides were mounted using Vectashield with DAPI.

In situ Hybridization {#s4h}
---------------------

In situ hybridization on paraffin sections of formalin-fixed lungs was performed as previously described [@pone.0071426-DeLanghe1]. A 584-bp *Fgf10* mouse cDNA [@pone.0071426-Bellusci1] and 201-bp fragment of *c-Myc* [@pone.0071426-DeLanghe1] mouse cDNA were used as templates for the synthesis of digoxigenin-labeled antisense riboprobes.

Statistics {#s4i}
----------

For BrdU labeling and qPCR analysis, each experiment was repeated with samples obtained from at least 3 different lungs preparations. All results are expressed as mean ± SEM. The significance of differences between 2 sample means was determined by the Student's t test. *P* values less than 0.05 were considered statistically significant.
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